Related Experiment Video
Updated: Nov 12, 2025
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.8K
Ravidasvir hydrochloride for genotype 1 hepatitis C treatment
Drugs of Today (Barcelona, Spain : 1998)
|March 17, 2021
Summary
New direct-acting antiviral regimens offer high cure rates for hepatitis C virus (HCV) infection. Ravidasvir hydrochloride, an HCV-NS5A inhibitor, shows promise in combination therapy for HCV genotype 1.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern.
- Direct-acting antiviral (DAA) agents targeting HCV proteins have revolutionized treatment.
- HCV-NS5A inhibitors are crucial components of effective combination therapies.
Purpose of the Study:
- To evaluate the efficacy and safety of Ravidasvir hydrochloride as part of an oral combination regimen.
- To assess the role of this pan-genotypic HCV-NS5A inhibitor in treating HCV genotype 1.
- To determine the barrier to resistance for Ravidasvir hydrochloride in clinical settings.
Main Methods:
- Clinical trials involving patients with HCV genotype 1.
- Combination therapy utilizing Ravidasvir hydrochloride with other DAAs.
- Assessment of efficacy, safety, and resistance profiles.
Main Results:
- Ravidasvir hydrochloride demonstrated impressive efficacy in combination therapy.
- The drug exhibited a favorable safety profile across trials.
- A high barrier to resistance was observed for Ravidasvir hydrochloride.
Conclusions:
- Ravidasvir hydrochloride is a potent pan-genotypic HCV-NS5A inhibitor.
- It serves as a key component in effective combination regimens for HCV genotype 1.
- The drug offers a high cure rate and a high barrier to resistance.
Related Concept Videos
01:10Retrovirus Life Cycles
48.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.3K
01:29Subviral Agents
281
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
281
02:33Retroviruses
13.3K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
13.3K
01:29Viruses with RNA Genomes
350
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
350